William Blair & Company’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $25.3M | Sell |
315,690
-29,110
| -8% | -$2.4M | 0.07% | 219 |
|
|
2025
Q4 | $29.4M | Sell |
344,800
-27,553
| -7% | -$2.26M | 0.08% | 186 |
|
|
2025
Q3 | $29M | Sell |
372,353
-17,780
| -5% | -$1.39M | 0.08% | 189 |
|
|
2025
Q2 | $30.5M | Sell |
390,133
-30,093
| -7% | -$2.24M | 0.08% | 183 |
|
|
2025
Q1 | $30.5M | Sell |
420,226
-106,066
| -20% | -$7.59M | 0.09% | 175 |
|
|
2024
Q4 | $39M | Sell |
526,292
-77,310
| -13% | -$5.41M | 0.11% | 159 |
|
|
2024
Q3 | $39.8M | Sell |
603,602
-123,931
| -17% | -$9M | 0.12% | 148 |
|
|
2024
Q2 | $67.2M | Sell |
727,533
-193,243
| -21% | -$17.1M | 0.21% | 109 |
|
|
2024
Q1 | $88M | Sell |
920,776
-24,905
| -3% | -$2.09M | 0.28% | 92 |
|
|
2023
Q4 | $72.1M | Sell |
945,681
-59,594
| -6% | -$4.15M | 0.25% | 94 |
|
|
2023
Q3 | $69.6M | Sell |
1,005,275
-56,394
| -5% | -$4.53M | 0.27% | 88 |
|
|
2023
Q2 | $100M | Buy |
1,061,669
+32,547
| +3% | +$2.83M | 0.37% | 68 |
|
|
2023
Q1 | $85.1M | Sell |
1,029,122
-78,820
| -7% | -$6.2M | 0.34% | 73 |
|
|
2022
Q4 | $82.7M | Sell |
1,107,942
-33,739
| -3% | -$2.6M | 0.36% | 71 |
|
|
2022
Q3 | $94.3M | Buy |
1,141,681
+189
| +0% | +$18.2K | 0.43% | 56 |
|
|
2022
Q2 | $109M | Buy |
1,141,492
+218,926
| +24% | +$22.7M | 0.48% | 49 |
|
|
2022
Q1 | $109M | Sell |
922,566
-22,902
| -2% | -$2.57M | 0.38% | 64 |
|
|
2021
Q4 | $122M | Buy |
945,468
+21,684
| +2% | +$2.53M | 0.38% | 58 |
|
|
2021
Q3 | $105M | Sell |
923,784
-629
| -0.1% | -$71.8K | 0.36% | 66 |
|
|
2021
Q2 | $95.7M | Buy |
924,413
+28,241
| +3% | +$2.66M | 0.33% | 71 |
|
|
2021
Q1 | $75M | Sell |
896,172
-2,678
| -0.3% | -$226K | 0.28% | 81 |
|
|
2020
Q4 | $82M | Buy |
898,850
+16,425
| +2% | +$1.36M | 0.3% | 77 |
|
|
2020
Q3 | $70.4M | Sell |
882,425
-7,981
| -0.9% | -$623K | 0.3% | 75 |
|
|
2020
Q2 | $61.5M | Buy |
890,406
+1,770
| +0.2% | +$126K | 0.29% | 73 |
|
|
2020
Q1 | $55.9M | Sell |
888,636
-25,371
| -3% | -$1.83M | 0.35% | 63 |
|
|
2019
Q4 | $71.1M | Sell |
914,007
-4,335
| -0.5% | -$339K | 0.37% | 67 |
|
|
2019
Q3 | $67.3M | Buy |
918,342
+3,429
| +0.4% | +$241K | 0.39% | 61 |
|
|
2019
Q2 | $56.3M | Buy |
914,913
+37,770
| +4% | +$2.28M | 0.32% | 78 |
|
|
2019
Q1 | $55.9M | Buy |
877,143
+27,183
| +3% | +$1.55M | 0.34% | 75 |
|
|
2018
Q4 | $43.4M | Sell |
849,960
-9,843
| -1% | -$498K | 0.32% | 81 |
|
|
2018
Q3 | $49.9M | Sell |
859,803
-21,774
| -2% | -$1.06M | 0.31% | 83 |
|
|
2018
Q2 | $42.8M | Sell |
881,577
-160,209
| -15% | -$7.48M | 0.29% | 86 |
|
|
2018
Q1 | $48.5M | Sell |
1,041,786
-426,348
| -29% | -$18.5M | 0.34% | 73 |
|
|
2017
Q4 | $55.2M | Sell |
1,468,134
-41,889
| -3% | -$1.54M | 0.37% | 65 |
|
|
2017
Q3 | $55M | Sell |
1,510,023
-22,083
| -1% | -$842K | 0.41% | 63 |
|
|
2017
Q2 | $60.4M | Buy |
1,532,106
+174,441
| +13% | +$6.37M | 0.45% | 57 |
|
|
2017
Q1 | $42.6M | Buy |
1,357,665
+324,957
| +31% | +$10.2M | 0.34% | 79 |
|
|
2016
Q4 | $32.3M | Buy |
1,032,708
+953,286
| +1,200% | +$30.9M | 0.29% | 94 |
|
|
2016
Q3 | $3.19M | Buy |
79,422
+15,927
| +25% | +$600K | 0.03% | 397 |
|
|
2016
Q2 | $2.11M | Buy |
63,495
+11,124
| +21% | +$381K | 0.02% | 467 |
|
|
2016
Q1 | $1.54M | Buy |
52,371
+13,785
| +36% | +$380K | 0.01% | 512 |
|
|
2015
Q4 | $1.02M | Buy |
38,586
+25,830
| +202% | +$671K | 0.01% | 628 |
|
|
2015
Q3 | $302K | Sell |
12,756
-6,438
| -34% | -$155K | ﹤0.01% | 1139 |
|
|
2015
Q2 | $455K | Sell |
19,194
-26,184
| -58% | -$591K | ﹤0.01% | 1787 |
|
|
2015
Q1 | $1.08M | Buy |
45,378
+12,030
| +36% | +$270K | ﹤0.01% | 1531 |
|
|
2014
Q4 | $708K | Buy |
33,348
+19,206
| +136% | +$386K | ﹤0.01% | 1596 |
|
|
2014
Q3 | $240K | Sell |
14,142
-3,150
| -18% | -$49.7K | ﹤0.01% | 1913 |
|
|
2014
Q2 | $247K | Hold |
17,292
| – | – | ﹤0.01% | 1877 |
|
|
2014
Q1 | $213K | Sell |
17,292
-30,060
| -63% | -$347K | ﹤0.01% | 1885 |
|
|
2013
Q4 | $519K | Sell |
47,352
-65,196
| -58% | -$735K | ﹤0.01% | 1581 |
|
|
2013
Q3 | $1.3M | Buy |
112,548
+150
| +0.1% | +$1.75K | ﹤0.01% | 1262 |
|
|
2013
Q2 | $1.26M | Buy |
+112,398
| New | +$1.33M | ﹤0.01% | 1198 |
|
Other funds holding EW
VCM
VPM
William Blair & Company's EW Position: Q1 2026 in Review
William Blair & Company reduced its Edwards Lifesciences (EW) stake by 8.4% in Q1 2026, selling an estimated $2.4M and leaving 315,690 shares worth $25.3M. The position accounts for 0.07% of the portfolio, ranked #219.
William Blair & Company first reported a position in EW in Q2 2013 and has held it in 52 quarters since. The position peaked at $122M in Q4 2021. 1,285 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- William Blair & Company held 315,690 shares of Edwards Lifesciences worth $25.3M as of Q1 2026.
- William Blair & Company sold 29,110 Edwards Lifesciences shares in Q1 2026, an estimated $2.4M.
- Edwards Lifesciences made up 0.07% of William Blair & Company's portfolio in Q1 2026, its #219 holding.
- William Blair & Company first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 52 quarters since.
- William Blair & Company's Edwards Lifesciences position peaked at $122M in Q4 2021.
- 1,285 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on William Blair & Company's 13F filing for Q1 2026, filed 8 May 2026.